M.S. (Branch-1) General Surgery Paper-IV - July 2022 - Detailed Answers

QUESTION 1 (30 Marks)

Principles and Recent Trends in Metabolic Surgery

Definition and Conceptual Shift

• Schwartz's Principles of Surgery, 11th Ed.

Patient Selection Criteria

Historical Background

• 1950s: Ileocolic bypass operations for severe hyperlipidemia - abandoned due to liver failure and severe nutritional complications
• Jejunoileal bypass: Severe diarrhea, electrolyte disturbances, renal stones, liver failure
• 1969: Mason and Ito - first gastric bypass (loop of jejunum to transverse proximal gastric pouch)
• Early 1980s: Scopinaro developed biliopancreatic diversion (BPD) in Italy
• BPD with duodenal switch (DS): Only major malabsorptive operation currently in use
• 1994: Belachew - first laparoscopic adjustable gastric banding (LAGB); Wittgrove and Clark - first laparoscopic RYGB
• 2008 onwards: Sleeve gastrectomy (SG) as primary bariatric operation grew rapidly

Common Procedures (Recent Trends)

1. Laparoscopic Roux-en-Y Gastric Bypass (LRYGB)

• Gold standard metabolic procedure
• Creates a small gastric pouch (15-30 mL), Roux limb of jejunum 75-150 cm bypasses the stomach/duodenum/proximal jejunum
• Produces both restriction and metabolic effects
• Superior T2DM remission rates

2. Laparoscopic Sleeve Gastrectomy (LSG)

• Resection of ~80% of the greater curvature of the stomach along a 32-36 Fr bougie
• Eliminates the fundus (main site of ghrelin production)
• Now the most commonly performed bariatric procedure worldwide
• Simpler than RYGB, no anastomosis

3. Laparoscopic Adjustable Gastric Banding (LAGB)

• Purely restrictive mechanism
• Metabolic effects are mostly due to weight loss (unlike RYGB/SG)
• Behavioral and gut hormone changes are much less dramatic
• Declining in use due to long-term complications

4. Biliopancreatic Diversion with Duodenal Switch (BPD/DS)

• Most potent metabolic and weight loss procedure
• Carries the highest complication and nutritional deficiency rates
• Requires lifelong nutritional supplementation

5. Single Anastomosis Duodeno-ileal Bypass with Sleeve (SADI-S) - newer trend

• Single anastomosis modification of DS

Mechanisms of Action

Weight Loss Mechanisms:

1. Gastric restriction - reduced caloric intake (all procedures to varying degrees)
2. Malabsorption - proximal bowel bypass (RYGB, BPD/DS)
3. Gut hormone changes - GLP-1, PYY, ghrelin
4. Neuronal effects - decreased activation of food reward centers (fMRI evidence post-RYGB); altered stretch-sensitive vagal endings produce early satiety
5. Gut microbiota changes - In obesity, elevated Firmicutes:Bacteroidetes ratio. Post-RYGB: Firmicutes decrease, Bacteroides/Prevotella increase. Bacteria transplant replicates some benefits of bypass surgery
6. Bile acid metabolism - Serum bile acids increase post-bypass. Bile acids activate TGR5 on L cells (GLP-1 secretion) and FXR in jejunum (lipid/glucose regulation). Bariatric surgery alters bile acid enterohepatic circulation in favor of weight loss and NASH resolution

Metabolic Effects (T2DM Remission):

• Foregut hypothesis: Bypassing the upper small intestine reduces nutrient-dependent hormonal actions that impair glucose tolerance
• Hindgut hypothesis: Rapid delivery of nutrients to distal intestine increases GLP-1/PYY secretion (ileal brake)
• Current evidence shows both LRYGB and SG produce metabolic improvements beyond those explained by weight loss alone
• High-quality RCT data: bariatric procedures more effective than medical/lifestyle interventions for inducing T2DM remission, even in less obese patients (BMI 30-35)

Results of Bariatric/Metabolic Surgery

• Weight loss: ~60-80% excess body weight loss at 1 year (RYGB/SG); 40-50% (LAGB)
• T2DM remission: ~60-80% with RYGB at 1-2 years; partial remission in most remaining patients
• Lipid improvement: Significant reduction in LDL, triglycerides; HDL increase
• Hypertension: Remission in 60-75% of patients
• NASH: Improvement or resolution
• Improved survival: Long-term observational studies show durable weight loss, diabetes remission, and improved survival
• Lifestyle intervention alone achieves mean weight loss of only 5-8%

Complications (Incidence 4-25%)

• RYGB specific: Internal hernias (Peterson's space, Roux limb mesenteric defect) - bowel obstruction after laparoscopic gastric bypass requires surgical (not conservative) management due to risk of internal hernia and bowel infarction; anastomotic leak; marginal ulcer; dumping syndrome
• SG specific: Staple line leak, gastroesophageal reflux worsening
• LAGB specific: Band slippage, erosion, port complications, esophageal dilatation
• All procedures: Nutritional deficiencies (iron, B12, folate, calcium, vitamin D)

Recent Trends in Metabolic Surgery

1. Metabolic surgery for lower BMI - Evidence for T2DM treatment even at BMI 30-34.9
2. Endoscopic bariatric interventions - Intragastric balloons, endoscopic sleeve gastroplasty, aspiration therapy
3. Single anastomosis procedures - Mini-gastric bypass (MGB/OAGB), SADI-S
4. Revision/conversion bariatric surgery - Growing need; indications include insufficient weight loss, weight regain, or complications
5. Adolescent bariatric surgery - LSG and RYGB now accepted in carefully selected adolescents
6. Staged approach with complex ventral hernia - Neoadjuvant metabolic surgery to reduce BMI before hernia repair (staged approach preferred: mean BMI at hernia repair 34 vs 42.4 kg/m² in synchronous group, with 6.7% vs 24% recurrence at 4.6 years)
7. GLP-1 receptor agonists - Semaglutide and tirzepatide achieving substantial weight loss; may compete with or complement surgical approaches
8. Microbiome manipulation - Fecal transplant, probiotics (oral lactobacillus post-RYGB increases weight loss)
9. Quality assurance - MBSAQIP (Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program)
10. Cost-effectiveness analysis - Long-term cost savings due to reduction in comorbidity burden

QUESTION 2 (20 Marks)

Anterior vs. Posterior Component Separation for Complex Incisional Hernia

Introduction

ANTERIOR COMPONENT SEPARATION (ACS)

Principle

Steps

1. Wide skin and subcutaneous tissue flaps raised laterally (extensive subcutaneous dissection)
2. External oblique aponeurosis incised 1-2 cm lateral to the semilunar line, from costal margin down to inguinal ligament
3. The external oblique is separated from the internal oblique in the relatively avascular plane
4. Optional: Division of the posterior rectus sheath (adds extra advancement)

Advancement Achievable

• 5 cm advancement per side at the waist level
• Total midline advancement: up to 10 cm (bilateral)
• More at epigastrium and less at pelvis

Advantages

• Technically simpler and familiar
• No need for specialized equipment
• Good fascial advancement

Disadvantages

• Wide subcutaneous flap devascularizes the skin - increased risk of wound complications (seroma, necrosis, SSI, skin flap necrosis)
• High surgical site occurrence (SSO) rate: 25-50%
• Perforating vessels from epigastric system are disrupted
• Not suitable for patients with midline skin loss or enterocutaneous fistulas
• Cannot be used in contaminated fields where biological mesh is needed

POSTERIOR COMPONENT SEPARATION (PCS) / Transversus Abdominis Release (TAR)

Principle

Steps (Rives-Stoppa Retromuscular Repair + TAR)

1. Enter retrorectus space by incising medial attachment of posterior rectus sheath
2. Develop retrorectus space bilaterally
3. At the lateral limit of the retrorectus space (linea semilunaris), identify the transversus abdominis muscle posterior to the rectus
4. Divide the transversus abdominis muscle and its posterior fascia (TAR proper)
5. This opens the preperitoneal space lateral to the semilunar line
6. Large mesh is placed in the retromuscular/preperitoneal plane and extends far lateral - mesh coverage of 15-20 cm lateral extent possible
7. Posterior layer (peritoneum/posterior fascia) is closed; mesh is sandwiched between posterior layer and rectus muscles

Advancement Achievable

• Significantly greater than ACS: up to 6-8 cm per side
• Particularly effective for large (>10 cm) defects and defects near the pubis/pelvis

Advantages

• Preserves skin perfusion - no wide subcutaneous flap; skin blood supply intact
• Dramatically lower wound complication rates
• Large retromuscular mesh placement (uncoated polypropylene acceptable - not in contact with viscera)
• Mesh is sandwiched in a well-vascularized plane
• Can be performed laparoscopically/robotically (eTEP - extended totally extraperitoneal approach)
• Allows mesh extension inferiorly to the pubic symphysis and iliopectineal ligament (Retzius space access)
• Preferable in contaminated fields since mesh is extraperitoneal

Disadvantages

• Technically more demanding
• Risk of peritoneal entry during TAR
• Risk of injury to lateral neurovascular bundles (intercostal nerves T7-T12, L1 - if too lateral)
• Learning curve longer than ACS

Comparison Table

Indications

• ACS preferred: When posterior approach is not feasible; less experienced center; no robotic platform; smaller defects where ACS gives sufficient advancement
• TAR/PCS preferred: Large defects (>10 cm), recurrent hernias, contaminated field, enterocutaneous fistula, previous anterior component separation failure, requirement for large mesh placement, periumbilical hernias with diastasis

Minimally Invasive Component Separation

• Access to retrorectus space via direct port placement
• "Crossover maneuver" bridges bilateral retrorectus spaces through midline preperitoneal space
• Relative contraindication: xiphopubic incision disrupting midline preperitoneal space

QUESTION 3 (20 Marks)

Laparoscopic Adrenalectomy

Introduction

Indications

• Functional tumors: Pheochromocytoma, Conn's adenoma (primary hyperaldosteronism), Cushing's syndrome (adrenocortical adenoma)
• Non-functional adenomas >4 cm or those showing growth on serial imaging
• Adrenocortical carcinoma (selected cases; >6 cm is relative contraindication for laparoscopic approach)
• Adrenal metastasis (isolated)
• Myelolipoma
• Bilateral adrenalectomy (Cushing's disease refractory to treatment)

Contraindications

• Large tumors (>10-12 cm) - relative contraindication
• Suspected malignancy with local invasion
• Pheochromocytoma in hemodynamically unstable patient (ensure pharmacological preparation first)
• Uncorrected coagulopathy
• Previous retroperitoneal surgery (relative - may favor transabdominal approach)

Pre-operative Preparation

• Biochemical evaluation to determine tumor function
• For pheochromocytoma: alpha-blockade (phenoxybenzamine or selective alpha-1 blockers) for 10-14 days, followed by beta-blockade; IV fluids to expand blood volume
• Cross-sectional imaging (CT/MRI) for anatomy
• Selective venous sampling for bilateral Conn's disease
• Correction of electrolyte abnormalities (hypokalemia in Conn's)

Approaches

1. Transperitoneal Laparoscopic Approach (Most Common)

Right Transperitoneal Laparoscopic Adrenalectomy

1. Position: Right side up (left lateral decubitus)
2. Ports: Four ports along the right costal margin from xiphoid to midaxillary line
3. Fan retractor in most medial port; camera in second most medial port
4. Hepatic flexure of colon freed and retracted inferomedially
5. Fan retractor retracts right lobe of liver medially; right triangular ligament taken down with hook electrocautery
6. Dissection begins at superolateral border of periadrenal fat
7. Proceed medially along superior border toward IVC
8. Critical step: Adrenal vein - short, drains directly into IVC at approximately right angle near the superomedial border
9. Adrenal vein clipped (2 clips proximally, 1 distally) and divided
10. After ligation, medial plane opens significantly; inferomedial dissection completed
11. Specimen placed in endocatch bag and retrieved

• Maingot's Abdominal Operations

Left Transperitoneal Laparoscopic Adrenalectomy

1. Position: Left side up (right lateral decubitus)
2. Ports: Three ports used
3. Initial phase: Limited medial visceral rotation of the splenic flexure, spleen and pancreatic tail
4. Divide lateral peritoneal attachments of colon and anterior layer of lienorenal ligament (1 cm from spleen) until gastric fundus is visible
5. Gravity and dissection allow spleen and pancreatic tail to "fall" medially - exposes kidney/perinephric fat in Gerota's fascia
6. Open Gerota's fascia; identify left adrenal vein (drains into left renal vein)
7. Adrenal vein clipped and divided
8. Tumour retracted away from renal hilum; resection completed along superior, inferior, and lateral borders
9. Inferior phrenic tributary may be encountered - clip and divide
10. Place in retrieval bag

• Bailey and Love's Short Practice of Surgery 28th Ed.

2. Posterior Retroperitoneoscopic Adrenalectomy (PRA)

• Balloon dissector creates retroperitoneal working space
• Direct access to adrenal gland without bowel manipulation
• Shorter operative time in experienced hands
• No risk of inadvertent visceral injury

Intraoperative Considerations

• Pheochromocytoma: Minimize gland manipulation before vein ligation; arterial and central venous monitoring mandatory; vasopressors and antihypertensives on standby; communicate with anesthetist
• Hemostasis: Small amounts of blood significantly impair visualization - careful electrocautery required
• Capsule preservation: Do not directly grasp adrenal tissue - risk of capsular rupture and tumor spillage (especially for adrenocortical carcinoma and pheo)
• Adrenal vein: The most critical step - right adrenal vein is short (2-5 mm); left is longer
• Conversion to open: If uncontrolled bleeding, suspected malignancy with invasion, or poor exposure

Complications

• Hemorrhage (most feared - especially right adrenal vein injury with IVC bleeding)
• Injury to adjacent structures (liver, spleen, pancreas, IVC, renal vessels, diaphragm)
• Port site hernia
• Adrenal insufficiency (bilateral adrenalectomy)
• Hypertensive crisis (pheochromocytoma - perioperative)
• Hypotension after pheo removal (volume depletion, residual alpha-blockade)

Outcomes

• Hospital stay: 1-2 days (vs 5-7 days for open)
• Morbidity: Significantly lower than open
• Conversion rate: 2-5%
• Recurrence: Rare for benign adenomas

QUESTION 4 (30 Marks - Short Notes)

4(1) - SCOLA (Sub Cutaneous Onlay Laparoscopic Approach) for Ventral Hernia

Definition

Concept

• Hybrid approach combining laparoscopic technique with an onlay mesh position
• Avoids intraperitoneal mesh placement (no contact with bowel)
• No requirement for coated/composite mesh - uncoated polypropylene can be used
• Primarily described for midline ventral hernias including umbilical hernia and rectus abdominis diastasis

Technical Description

1. Port placement: Two or three subcutaneous trocars placed in the subcutaneous space lateral to the hernia
2. Insufflation of subcutaneous space: CO₂ is used to create a working space in the subcutaneous layer overlying the anterior rectus sheath (as illustrated in Figure 80.8 in Sabiston - "Insufflation of subcutaneous space during SCOLA")
3. Dissection: The subcutaneous space is developed using laparoscopic instruments under direct vision
4. Defect closure: The fascial defect is closed laparoscopically using suture (defect repair)
5. Mesh placement: Mesh is placed in the onlay position on top of the anterior rectus sheath
6. Fixation: Mesh is fixed with tacks or sutures

Advantages

• No intraperitoneal entry - avoids visceral injury and intraabdominal adhesions
• No need for expensive coated/composite mesh
• Can be used for diastasis recti repair simultaneously
• Avoids large subcutaneous skin flaps of open surgery (less wound morbidity than open onlay)
• Day-case or short-stay procedure

Indications

• Small to medium ventral/umbilical hernias
• Rectus abdominis diastasis with/without hernia
• Patients where intraperitoneal mesh is to be avoided

Limitations

• Limited to midline/small hernias
• Learning curve for creating subcutaneous working space
• Long-term recurrence data still limited (relatively new technique)
• Not suitable for large complex hernias requiring component separation

4(2) - Robotic Surgery vs. Laparoscopic Surgery

Background

Comparison Table

Advantages of Robotic Surgery Over Laparoscopy

1. Wristed instruments allow complex intra-corporeal suturing (complex anastomoses, intracorporeal knot-tying)
2. Eliminates physiologic tremor
3. Superior 3D visualization
4. Ergonomic advantage - reduces surgeon fatigue for long procedures
5. Easier for retrorectal/pelvic dissection (narrow spaces)
6. Beneficial in complex hernia repair (eTEP-TAR), Whipple procedure, low rectal dissection (TME), radical prostatectomy

Advantages of Laparoscopy Over Robotic Surgery

1. Lower cost - economically accessible worldwide
2. Tactile (haptic) feedback preserved
3. Shorter setup and operating room turnover time
4. More flexible port placement
5. Can be converted to hand-assisted easily
6. Widely available; less resource-intensive

Current Clinical Evidence

• Prostatectomy (RARP): Robotic approach is now gold standard; superior continence and potency preservation
• Hernia repair: Robotic ventral hernia repair allows complex retromuscular repair (eTEP-TAR) with intracorporeal suturing; outcomes similar to laparoscopic with potential advantages
• Colorectal surgery: Robotic vs. laparoscopic shows similar oncological outcomes; robotic may reduce conversion rate in TME
• Cholecystectomy, appendectomy, fundoplication: No clear advantage for robotic over laparoscopic
• Pancreaticoduodenectomy: Robotic Whipple shows promise in high-volume centers

Verdict

4(3) - TIF (Trans Oral Incisionless Fundoplication)

Definition

Rationale

Device

• EsophyX device (EndoGastric Solutions) - introduced through the mouth
• Allows the surgeon (working from inside the stomach) to create full-thickness plications at the GEJ

Procedure (TIF 2.0 - Current Standard)

1. General anesthesia; patient in left lateral decubitus
2. Standard upper endoscopy first to assess anatomy and rule out Barrett's esophagus/dysplasia
3. EsophyX device introduced transorally into the stomach
4. Under endoscopic vision: device retroflex retroflexion - visualizes gastric cardia
5. Tissue invaginator grabs full-thickness tissue at the GEJ; H-fasteners (polypropylene) deployed to create a 270° circumferential valve 3-4 cm in length
6. Multiple fasteners placed to create a durable fundoplication
7. Reconstructed valve mimics the flap valve of the cardia

Indications

• Symptomatic GERD not adequately controlled with PPI therapy
• Small hiatal hernia (≤2 cm) - relative contraindication for large hiatal hernia
• Patients who wish to avoid laparoscopic surgery
• GERD with regurgitation predominant symptoms

Contraindications

• Large hiatal hernia (>2 cm)
• Barrett's esophagus with dysplasia
• Severe esophagitis (Grade C/D)
• Prior esophagogastric surgery
• BMI >35
• Poor esophageal motility

Outcomes

• 60-80% patients achieve significant reduction in GERD symptoms at 3 years
• 50-70% elimination of PPI use at 3 years
• Lower remission rates than Nissen fundoplication (gold standard)
• No skin incisions - very low complication rate
• Can be revised or followed by laparoscopic fundoplication if required

Advantages over Laparoscopic Fundoplication

• No abdominal incisions
• No general surgical complications (trocar injuries, pneumothorax)
• Shorter recovery (discharge same day or next day)
• Preserves option of future laparoscopic surgery
• No postoperative dysphagia in most cases

Disadvantages

• Less durable than Nissen fundoplication
• Not suitable for large hiatal hernias
• Cannot repair concomitant large paraesophageal hernias
• Higher recurrence and re-intervention rate at 5 years
• Requires specialized endoscopy training
• Cost of EsophyX device

Comparison with Nissen Fundoplication

Summary of Key Points for Exam